Find uplifting stories about heroes, innovations, and solutions
21 results for "sanofi"
Abu Dhabi's health authority is partnering with global pharmaceutical leader Sanofi to explore building a cutting-edge vaccine research center powered by AI and mRNA technology. The collaboration could accelerate how quickly new vaccines reach people who need them most.
Abu Dhabi is teaming up with global pharmaceutical company Sanofi to build a cutting-edge Vaccine Innovation Centre powered by artificial intelligence and mRNA technology. The facility will combine research, manufacturing, and pandemic preparedness under one roof to accelerate life-saving vaccine development.
A new documentary series reveals how pharmaceutical breakthroughs travel from laboratory discovery to millions of patients worldwide. Thousands of workers transform scientific hope into real medicines through cutting-edge technology and human dedication.
The FDA just approved teplizumab for children aged 8 and older with stage 3 type 1 diabetes, expanding treatment options for young patients. This marks an important step forward in managing a disease that affects over 300,000 American children.
Eight major pharmaceutical companies are investing $1.2 billion to help Mexico produce its own medications domestically. The initiative aims to lower drug costs and reduce the country's dependence on imported medicines.
A single-dose treatment for sleeping sickness just received European approval, replacing brutal treatments with three tablets. The breakthrough brings Africa within reach of eliminating a disease that killed tens of thousands just two decades ago.
Scientists can now access Claude Science, a powerful AI platform designed to accelerate medical research and help develop life-saving treatments faster. Major pharmaceutical companies are already using the technology to compress research timelines that once took years into months.
Major global companies are partnering with Singapore startups to transform waste into valuable resources while slashing carbon emissions. From robots sorting electronic waste to medical plastics paving roads, these collaborations are proving sustainability drives profit and growth.
A renewable energy company is creating 90 new jobs across Ireland and the UK as demand for solar and battery storage solutions soars. The expansion comes as businesses rush to meet new sustainability requirements and cut their carbon footprints.
A groundbreaking treatment can now delay type 1 diabetes for up to three years, giving families precious time before symptoms begin. The NHS has approved the first-ever drug that stops the disease in its tracks during early stages.
Two children in British Columbia just became the first in Canada to receive a medication that can delay type 1 diabetes by years. This marks a turning point for families who have spent decades waiting for treatments that change the disease course, not just manage symptoms.
A new therapeutic vaccine targeting acne-causing bacteria has entered clinical trials in China, offering hope for millions who struggle with treatment-resistant breakouts. The protein-based shot marks a global shift toward immune-based solutions for the world's eighth most common skin condition.
Sixteen major pharmaceutical companies agreed to cut prescription drug prices for Americans through a new discount platform called TrumpRx. Popular medications including weight-loss drugs, diabetes treatments, and asthma inhalers will now cost significantly less for millions of consumers.
A new flu vaccine using the same technology that powered COVID shots just proved more effective than traditional options in a 40,000-person study. The breakthrough could reshape how we protect ourselves from seasonal flu.
Australia just approved the first new type 1 diabetes therapy since insulin was discovered over a century ago. The treatment can delay disease progression by an average of two years, giving families precious time before daily insulin begins.
A groundbreaking treatment just approved in England could transform life for nearly 30,000 people struggling to breathe with chronic lung disease. The twice-monthly injection is the first to tackle both symptoms and root causes of COPD.
A single-dose pill that cures sleeping sickness in one day just received approval, replacing treatments that once required 10 days or dangerous arsenic injections. After decades of African-led research, this breakthrough could help eliminate a disease that's killed millions.
A breakthrough eczema treatment matches leading medications but requires injections only twice a year instead of every two weeks. Apogee Therapeutics' study shows patients maintained clear, itch-free skin with dramatically fewer doctor visits.
Nearly 30,000 people in England with chronic lung disease will gain access to the first treatment that targets an underlying cause, not just symptoms. The twice-monthly injection cuts severe flare-ups by 30% and could save the NHS millions.
Two children at BC Children's Hospital became the first in Canada to receive a treatment that can delay type 1 diabetes by about two years. This marks a historic shift from just managing the disease to actually changing its course.
Showing 20 of 21